H.R. 4084 (119th)Bill Overview

Access to Birth Control Act

Health|Civil actions and liabilityDrug therapy
Cosponsors
Support
Democratic
Introduced
Jun 23, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill, titled the Access to Birth Control Act, would add a new section to the Public Health Service Act requiring pharmacies that receive FDA-approved contraceptives or related medications in interstate commerce to provide them to customers promptly when in stock. If an item is not in stock and the pharmacy normally carries contraception, the pharmacy must notify the customer and either refer/transfer the prescription to a pharmacy that has it or promptly order it and notify the customer when it arrives.

Why people may split

Scope of access vs. conscience protections: liberals emphasize guaranteeing access and blocking RFRA defenses; conservatives emphasize religious freedom and conscience rights.

Watch point

Relative to its intended legislative type, this bill establishes detailed substantive requirements and remedies to ensure pharmacies dispense FDA-approved contraceptives and related medications, and it includes several defined exceptions and statutory definitions.

The bill, titled the Access to Birth Control Act, would add a new section to the Public Health Service Act requiring pharmacies that receive FDA-approved contraceptives or related medications in interstate commerce to provide them to customers promptly when in stock.

If an item is not in stock and the pharmacy normally carries contraception, the pharmacy must notify the customer and either refer/transfer the prescription to a pharmacy that has it or promptly order it and notify the customer when it arrives.

The bill bars certain behaviors by pharmacy employees (harassment, deception about availability, breaches of confidentiality, withholding a lawful prescription) and preserves limited refusals for lack of valid prescription, inability to pay, or a pharmacist acting on professional clinical judgment.

Passage30/100

Content-wise the bill is narrowly focused and implementable, which works in its favor. However, it addresses a politically sensitive issue (contraceptive access versus conscience/religious objections), removes a common legal defense, and imposes private liability and civil penalties—factors that typically generate strong opposition and legal scrutiny. Without clear built-in compromises or broad bipartisan safeguards, the legislative path (especially through the Senate) and ultimate enactment face significant obstacles.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes detailed substantive requirements and remedies to ensure pharmacies dispense FDA-approved contraceptives and related medications, and it includes several defined exceptions and statutory definitions. It is specific about on-the-ground obligations and private enforcement but leaves administrative enforcement mechanics, fiscal implications, and certain cross-law interactions under-specified.

Contention72/100

Scope of access vs. conscience protections: liberals emphasize guaranteeing access and blocking RFRA defenses; conservatives emphasize religious freedom and conscience rights.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesLocal governments · Federal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesLikely increases timely patient access to FDA-approved contraceptives and related medications (including emergency cont…
  • Potential benefitMay reduce unintended pregnancies and associated public health costs over time by improving access to contraception (su…
  • Potential benefitCould improve protections for privacy and reduce discriminatory or stigmatizing behavior in pharmacies by prohibiting i…
Likely burdened
  • Potential burdenImposes new compliance obligations, recordkeeping/training and potential legal exposure (civil penalties, private suits…
  • Local governmentsMay lead some pharmacies to stop 'ordinarily' stocking contraceptives to avoid the statute’s obligations or litigation…
  • Federal agenciesRaises federal–state authority tensions because pharmacy practice and professional discipline are primarily state-regul…
03 · Why people split

Why the argument around this bill splits.

Scope of access vs. conscience protections: liberals emphasize guaranteeing access and blocking RFRA defenses; conservatives emphasize religious freedom and conscience rights.
Progressive95%

A liberal/left-leaning observer would likely view the bill as a strong federal step to protect access to contraceptives and related medications, reduce discriminatory denials at pharmacies, and protect reproductive autonomy.

They would welcome the explicit prohibitions on harassment, deception, and confidentiality breaches and the private right of action as enforcement tools.

The removal of RFRA as a defense would be seen as closing a legal loophole used to deny services.

Leans supportive
Centrist70%

A centrist/moderate would likely view the bill as addressing a real access problem while raising concerns about operational clarity, burdens on pharmacies, and potential legal conflicts.

They would appreciate the aims of preventing unjustified denials and ensuring timely access, but want clearer definitions of terms like 'normally stock,' 'without delay,' and 'professional clinical judgment.' The centrist would be attentive to unintended costs and litigation risk for small pharmacies and the balance between federal standards and state regulation.

Leans supportive
Conservative15%

A mainstream conservative would likely view the bill as federal overreach that interferes with pharmacists' conscience rights and imposes liability and operational burdens on small businesses.

They would be particularly concerned that the bill disallows RFRA as a defense and creates a broad private right of action with punitive damages and daily civil penalties.

They would also see potential conflicts with state regulations and professional standards and worry about compelled participation in services that conflict with religious or moral beliefs.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Content-wise the bill is narrowly focused and implementable, which works in its favor. However, it addresses a politically sensitive issue (contraceptive access versus conscience/religious objections), removes a common legal defense, and imposes private liability and civil penalties—factors that typically generate strong opposition and legal scrutiny. Without clear built-in compromises or broad bipartisan safeguards, the legislative path (especially through the Senate) and ultimate enactment face significant obstacles.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • Magnitude and organization of stakeholder opposition or support (pharmacy chains, pharmacists’ associations, religious liberty groups, reproductive rights advocates) and how that affects committee and floor dynamics.
  • Whether cost and regulatory impact estimates (absent from the bill text) would reveal substantial compliance costs that change legislative appetite.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Scope of access vs. conscience protections: liberals emphasize guaranteeing access and blocking RFRA defenses; conservatives emphasize reli…

Content-wise the bill is narrowly focused and implementable, which works in its favor. However, it addresses a politically sensitive issue…

Unlocked analysis

Relative to its intended legislative type, this bill establishes detailed substantive requirements and remedies to ensure pharmacies dispense FDA-approved contraceptives and related medications, and it includes several…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis